The BOOM (British Orthopaedic Oncology Management)
A NATIONAL COLLABORATIVE PROJECT
Data collection – 1st April 2021 to 30th June 2021
REGISTER AS A COLLABORATOR NOW!
E-mail BOOS.ROH@nhs.net with your name, grade, speciality and hospital.
The Birmingham Orthopaedic Network (BON) and The British Orthopaedic Oncology Society (BOOS) have developed a national audit to assess the management of patients with metastatic bone disease against the British Orthopaedic Association and BOOS guidelines: Metastatic Bone Disease: A Guide to Good Practice.
Bone is a frequent site of metastasis and can represent significant morbidity to patients. The guidance created by BOOS & British Orthopaedic Association (BOA) in 2015 aimed to set a clear standard for provision of adequate levels of care for the management of metastatic bone disease.
However, since the release of this guidance it is unclear whether the recommendations have been adopted into clinical practice.
With the impending release of a British Orthopaedic Association Standard for Trauma (BOAST) relating to metastatic bone disease management, we hope to evaluate the current practice before this is released.
Following introduction of the BOAST, this evaluation will provide a baseline for comparison against in a future audit.